Clinical trial
Combination Chemotherapy in Treating Young Patients With Langerhans Cell…
NCT00276757 · Histiocyte Society, Other · Completed
Key facts
| NCT number | NCT00276757 |
|---|---|
| Title | Combination Chemotherapy in Treating Young Patients With Langerhans Cell Histiocytosis |
| Official title | Treatment Protocol of the Third International Study For Langerhans Cell Histiocytosis |
| Lead sponsor | Histiocyte Society, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Childhood Langerhans Cell Histiocytosis |
| Intervention type | Drug |
| Interventions | leucovorin calcium, methotrexate, prednisolone, vinblastine sulfate |
| Enrollment | 376 |
| Start date | Apr 1, 2001 |
| Completion | Jun 1, 2013 |
| First posted | Jan 13, 2006 |
| Last update posted | Jan 10, 2014 |
| Countries | Argentina, Austria, Canada, France, Germany, Ireland, Italy, Sweden, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: